다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Journal of Korean medical science : JKMS, v.20 no.2 = no.102, 2005년, pp.169 - 176
Yoo, Jin-Hong (Department of Internal Medicine, The Catholic Haematopoietic Stem Cell Transplantion Center, The Catholic University of Korea, College of Medicine, Seoul, Korea.) , Lee, Dong-Gun (Department of Internal Medicine, The Catholic Haematopoietic Stem Cell Transplantion Center, The Catholic University of Korea, College of Medicine, Seoul, Korea.) , Choi, Su Mi (Department of Internal Medicine, The Catholic Haematopoietic Stem Cell Transplantion Center, The Catholic University of Korea, College of Medicine, Seoul, Korea.) , Choi, Jung-Hyun (Department of Internal Medicine, The Catholic Haematopoietic Stem Cell Transplantion Center, The Catholic University of Korea, College of Medicine, Seoul, Korea.) , Shin, Wan-Shik (Department of Internal Medicine, The Catholic Haematopoietic Stem Cell Transplantion Center, The Catholic University of Korea, College of Medicine, Seoul, Korea.) , Kim, Myungshin (Department of Internal Medicine, The Catholic Haematopoietic Stem Cell Transplantion Center, The Catholic University of Korea, College of Medicine, Seoul, Korea.) , Yong, Dongeun (Department of La) , Lee, Kyungwon , Min, Woo-Sung , Kim, Chun-Choo
AI-Helper
An increase in vancomycin-resistant enterococcal (VRE) bacteremia in hemato-oncological patients (n=19) in our institution from 2000 through 2001 led us to analyze the molecular epidemiologic patterns and clinical features unique to our cases. The pulsed field gel electrophoresis of the isolates rev...
1 Cetinkaya Y Falk P Mayhall CG Vancomycin-resistant enterococci Clin Microbiol Rev 2000 13 686 707 11023964
2 Vergis EN Hayden MK Chow JW Snydman DR Zervos MJ Linden PK Wagener MM Schmitt B Muder RR Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia: a prospective multicenter study Ann Intern Med 2001 135 484 492 11578151
3 Lee K Jang SJ Lee HJ Ryoo N Kim M Hong SG Chong Y The Korean Nationwide Surveillance of Antimicrobial Resistance Group Increasing prevalence of vancomycin-resistant Enterococcus faecium, expanded-spectrum cephalosporin-resistant Klebsiella pneumoniae, and imipenem-resistant Pseudomonas aeruginosa in Korea: KONSAR Study in 2001 J Korean Med Sci 2004 19 8 14 14966334
4 Lee K Lee HS Jang SJ Park AJ Lee MH Song WK Chong Y Members of Korean Nationwide Surveillance of Antimicrobial Resistance Group Antimicrobial resistance surveillance of bacteria in 1999 in Korea with a special reference to resistance of enterococci to vancomycin and Gram-negative bacilli to third generation cephalosporin, imipenem, and fluoroquinolone J Korean Med Sci 2001 16 262 270 11447969
5 Lee WG Jernigan JA Rasheed JK Anderson GJ Tenover FC Possible horizontal transfer of the vanB2 gene among genetically diverse strains of vancomycin resistant Enterococcus faecium in a Korean hospital J Clin Microbiol 2001 39 1165 1168 11230450
6 Shin JW Yong D Kim MS Chang KH Lee K Kim JM Chong Y Sudden increase of vancomycin-resistant enterococcal infections in a Korean tertiary care hospital: possible consequences of increased use of oral vancomycin J Infect Chemother 2003 9 62 67 12673410
7 Garner JS Jarvis WR Emori TG Horan TC Hughes JM CDC definitions for nosocomial infections, 1988 Am J Infect Control 1988 16 128 140 2841893
8 Hughes WT Armstrong D Bodey GP Bow EJ Brown AE Calandra T Feld R Pizzo PA Rolston KV Shenep JL Young LS 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer Clin Infect Dis 2002 34 730 751 11850858
9 National Committee for Clinical Laboratory Standards Performance standards for antimicrobial susceptibility testing; Twelfth informational supplement 2002 Wayne, PA Natinal Committee for Clinical Laboratory Standards
10 Dutka-Malen S Evers S Courvalin P Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR J Clin Microbiol 1995 32 24 27 7699051
11 Le Gall JR Lemeshow S Saulnier F A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study JAMA 1993 270 2957 2963 8254858
12 Chadwick PR Oppenheim BA Fox A Woodford N Morgenstern GR Scarffe JH Epidemiology of an outbreak due to glycopeptide resistant Enterococcus faecium on a leukaemia unit J Hosp Infect 1996 34 171 182 8923271
13 Boyce JM Opal SM Chow JW Zervos MJ Potter-Bynoe G Sherman CB Romulo RL Fortna S Medeiros AA Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance J Clin Microbiol 1994 32 1148 1153 8051238
14 Boyle JF Soumakis SA Rendo A Herrington JA Gianarkis DG Thurberg BE Painter BG Epidemiologic analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci J Clin Microbiol 1993 31 1280 1285 8501230
15 Harbarth S Cosgrove S Carmeli Y Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant Enterococci Antimicrob Agents Chemother 2002 46 1619 1628 12019066
16 Nourse C Murphy H Byrne C O'Meara A Breatnach F Kaufmann M Clarke A Butler K Control of a nosocomial outbreak of vancomycin resistant Enterococcus faecium in a paediatric oncology unit: risk factors for colonisation Eur J Pediatr 1998 157 20 27 9461358
17 Suntharam N Lankford MG Trick WE Peterson LR Noskin GA Risk factors for acquisition of vancomycin resistant enterococci among haematology oncology patients Diagn Microbiol Infect Dis 2002 43 183 188 12106950
18 Bach PB Malak SF Jurcic J Gelfand SE Eagan J Little C Sepkowitz KA Impact of infection by vancomycin resistant Enterococcus on survival and resource utilization for patients with leukemia Infect Control Hosp Epidemiol 2002 23 471 474 12186216
19 Linden PK Pasculle AW Manez R Kramer DJ Fung JJ Pinna AD Kusne S Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium Clin Infect Dis 1996 22 663 670 8729206
20 Stosor V Peterson LR Postelnick M Noskin GA Enterococcus faecium bacteremia: does vancomycin resistance make a difference? Arch Intern Med 1998 158 522 527 9508230
21 Garbutt JM Ventrapragada M Littenberg B Mundy LM Association between resistance to vancomycin and death in cases of Enterococcus faecium bacteremia Clin Infect Dis 2000 30 466 472 10722429
22 Wells CL Juni BA Cameron SB Mason KR Dunn DL Ferrien P Rhame FS Stool carriage, clinical isolation, and mortality during an outbreak of vancomycin-resistant enterococci in hospitalized medical and/or surgical patients Clin Infect Dis 1995 21 45 50 7578758
23 Goff DA Sierawski SJ Clinical experience of quinupristin-dalfopristin for the treatment of antimicrobial-resistant gram-positive infections Pharmacotherapy 2002 22 748 758 12066965
24 Linden PK Moellering RC Jr Wood CA Rehm SJ Flaherty J Bompart F Talbot GH Synercid Emergency-Use Study Group Treatment of vancomycin-resistant Enterococcus faecium infections with quinupristin/dalfopristin Clin Infect Dis 2001 33 1816 1823 11668430
25 Moellering RC Quinupristin/dalfopristin: therapeutic potential for vancomycin-resistant enterococcal infections J Antimicrob Chemother 1999 44 Suppl 25 30 10511394
26 Moellering RC Linden PK Reinhardt J Blumberg EA Bompart F Talbot GH Synercid Emergency-Use Study Group The efficacy and safety of quinupristin/dalfopristin for the treatment of infections caused by vancomycin-resistant Enterococcus faecium J Antimicrob Chemother 1999 44 251 261 10473233
27 Winston DJ Emmanouilides C Kroeber A Hindler J Bruckner DA Territo MC Busuttil RW Quinupristin/Dalfopristin therapy for infections due to vancomycin-resistant Enterococcus faecium Clin Infect Dis 2000 30 790 797 10817685
28 Roghmann MC McCarter RJ Brewrink J Cross AS Morris JG Clostridium difficile infection is a risk factor for bacteremia due to vancomycin resistant enterococci (VRE) in VRE-colonized patients with acute leukemia Clin Infect Dis 1997 25 1056 1059 9402356
29 Timmers G van der Zwet WC Simoons-Smit IM Savelkoul PH Meester HH Vandenbroucke-Grauls CM Huijgens PC Outbreak of vancomycin-resistant Enterococcus faecium in a haematology unit: risk factor assessment and successful control of the epidemic Br J Haematol 2002 116 826 833 11886387
30 Edmond MB Ober JF Weinbaum DL Pfaller MA Hwang T Sanford MD Wenzel RP Vancomycin resistant Enterococcus faecium bacteremia: risk factors for infection Clin Infect Dis 1995 20 1126 1133 7619987
31 Falk PS Winnike J Woodmansee C Desai M Mayhall CG Outbreak of vancomycin resistant enterococci in a burn unit Infect Control Hosp Epidemiol 2000 21 575 582 11001260
32 Kuehnert MJ Jernigan JA Pullen AL Rimland D Jarvis WR Association between mucositis severity and vancomycin resistant enterococcal bloodstream infection in hospitalized cancer patients Infect Control Hosp Epidemiol 1999 20 660 663 10530642
33 Handwerger S Raucher B Altarac D Monka J Marchione S Singh KV Murray BE Wolff J Walters B Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin Clin Infect Dis 1993 16 750 755 8329505
34 Noskin GA Stosor V Cooper I Peterson LR Recovery of vancomycin resistant enterococci on fingertips and environmental surfaces Infect Control Hosp Epidemiol 1995 16 577 581 8568202
35 Porwancher R Sheth A Remphrey S Taylor E Hinkle C Zervos M Epidemiological study of hospital-acquired infection with vancomycin-resistant Enterococcus faecium: possible transmission by an electronic ear-probe thermometer Infect Control Hosp Epidemiol 1997 18 771 774 9397374
36 Dunne WM Jr Wang W Clonal dissemination and colony morphotype variation of vancomycin-resistant Enterococcus faecium isolates in metropolitan Detroit, Michigan J Clin Microbiol 1997 35 388 392 9003602
37 Fridkin SK Yokoe DS Whitney CG Onderdonk A Hooper DC Epidemiology of a dominant clonal strain of vancomycin-resistant Enterococcus faecium at separate hospitals in Boston, Massachusetts J Clin Microbiol 1998 36 965 970 9542917
38 Bonten MJ Hayden MK Nathan C van Voorhis J Matushek M Slaughter S Rice T Weinstein RA Epidemiology of colonization of patients and environment with vancomycin-resistant enterococci Lancet 1996 348 1615 1619 8961991
39 Chow JW Kuritza A Shlaes DM Green M Sahm DF Zervos MJ Clonal spread of vancomycin-resistant Enterococcus faecium between patients in three hospitals in two states J Clin Microbiol 1993 31 1609 1611 8315004
40 Morris JG Jr Shay DK Hebden JN McCarter RJ Jr Perdue BE Jarvis W Johnson JA Dowling TC Polish LB Schwalbe RS Enterococci resistant to multiple antimicrobial agents including vancomycin: establishment of endemicity in a university medical center Ann Intern Med 1995 123 250 259 7611590
41 Nourse C Byrne C Murphy H Kaufmann ME Clarke A Butler K Eradication of vancomycin resistant Enterococcus faecium from a pediatric oncology unit and prevalence of colonization in hospitalized and community-based children Epidemiol Infect 2000 124 53 59 10722130
42 Stosor V Kruszynski J Suriano T Noskin GA Peterson LR Molecular epidemiology of vancomycin-resistant Enterococci: a 2-year perspective Infect Control Hosp Epidemiol 1999 20 653 659 10530641
43 Montecalvo MA de Lencastre H Carraher M Gedris C Chung M VanHorn K Wormser GP Natural history of colonization with vancomycin resistant Enterococcus faecium Infect Control Hosp Epidemiol 1995 16 680 685 8683085
44 Garner JS Guideline for isolation precautions in hospitals Infect Control Hosp Epidemiol 1996 17 53 80 8789689
45 CDC Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee MMWR Recomm Rep 1995 44 1 13
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.